Skip to content


  • Correction
  • Open Access

Correction to: Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017

  • 1,
  • 2,
  • 3Email author,
  • 4,
  • 5, 6,
  • 7,
  • 8,
  • 9,
  • 10,
  • 11,
  • 12,
  • 13,
  • 14,
  • 15 and
  • 16, 17
Fluids and Barriers of the CNS201815:3

  • Received: 8 December 2017
  • Accepted: 12 December 2017
  • Published:

The original article was published in Fluids and Barriers of the CNS 2017 14:31

Correction to: Fluids Barriers CNS (2017) 14:31

After publication of the article [1], it has been brought to our attention that there are some errors in the formatting of names in the final version of the article.

Firstly, the article’s fifth author had their name spelt incorrectly. Previously included as “Roosmarijn E. Vandenbrouke”, the correct spelling is “Roosmarijn E. Vandenbroucke”. This error was present in the author list and page 3 of the article.

Furthermore, author names in the article references had formatting issues. This occurred in cases where “van” is part of the naming structure. In these cases the rest of the last name was included incorrectly as an initial. The references affected are listed below with their corrected author list.
  • Reference #7 should read: Vandenbroucke RE, Dejonckheere E, Van Lint P, Demeestere D, Van Wonterghem E, Vanlaere I, et al.

  • Reference #8 should read: Brkic M, Balusu S, Van Wonterghem E, Gorlé N, Benilova I, Kremer A, et al.

  • Reference #9 should read: Balusu S, Van Wonterghem E, De Rycke R, Raemdonck K, Stremersch S, Gevaert K, et al.

  • Reference #10 should read: Reijerkerk A, Lopez-Ramirez MA, van Het Hof B, Drexhage JA, Kamphuis WW, Kooij G, et al.

  • Reference #22 should read: Loryan I, Sinha V, Mackie C, Van Peer A, Drinkenburg W, Vermeulen A, et al.



Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

Institute of Ophthalmology, University College London, London, EC1V 9EL, UK
Department of Pharmaceutical Biosciences, Uppsala University, 751 24 Uppsala, Sweden
Gagle Brook House, Chesterton, Bicester, OX26 1UF, UK
Centre for Experimental Medicine, Queen’s University Belfast, Belfast, Northern Ireland, UK
Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium
VIB-UGent Center for Inflammation Research, VIB, Ghent, Belgium
School of Life, Health and Chemical Sciences, Open University, Milton Keynes, UK
Smurfit Institute of Genetics, Lincoln Place Gate, Trinity College Dublin, Dublin 2, Ireland
Institute of Pharmacy and Molecular Biotechnology, Ruprecht-Karls University, Heidelberg, Germany
Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
NEUWAY Pharma GmbH, Ludwig-Erhard-Allee 2, 53175 Bonn, Germany
2-BBB Medicines BV, Leiden, Netherlands
Institute of Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Lübeck, Germany
Antibody Discovery and Protein Engineering, MedImmune, Cambridge, UK
Ossianix Inc., Stevenage, UK
CNRS, NICN, Aix Marseille Univ, Marseille, France
Vect-Horus, Faculte de Medecine Nord, 51 Boulevard Pierre Dramard, Marseille, France


  1. Greenwood J, Hammarlund-Udenaes M, Jones HC, Stitt AW, Vandenbroucke RE, Romero IA, Campbell M, Fricker G, Brodin B, Manninga H, Gaillard PJ, Schwaninger M, Webster C, Wicher KB, Khrestchatisky M. Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017. Fluids Barriers CNS. 2017;14:31. ArticlePubMedPubMed CentralGoogle Scholar


© The Author(s) 2017